# Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke

**Authors:** Alex K Harris, Adviye Ergul, Anna Kozak, Livia S Machado, Maribeth H Johnson, Susan C Fagan

PMC · DOI: 10.1186/1471-2202-6-49 · BMC Neuroscience · 2005-08-03

## TL;DR

This study finds that neutrophils are not a major source of gelatinase activity or brain damage after a stroke.

## Contribution

The study demonstrates that neutrophils are not a significant contributor to gelatinase activity or acute brain damage after stroke.

## Key findings

- Neutrophil depletion did not reduce gelatinase (MMP-2 and MMP-9) expression or activity after stroke.
- Neutrophil depletion had no effect on edema, hemorrhage, or infarct size.
- Gelatinase activity increases after stroke even without circulating neutrophils.

## Abstract

While gelatinase (MMP-2 and -9) activity is increased after focal ischemia/reperfusion injury in the brain, the relative contribution of neutrophils to the MMP activity and to the development of hemorrhagic transformation remains unknown.

Anti-PMN treatment caused successful depletion of neutrophils in treated animals. There was no difference in either infarct volume or hemorrhage between control and PMN depleted animals. While there were significant increases in gelatinase (MMP-2 and MMP-9) expression and activity and edema formation associated with ischemia, neutrophil depletion failed to cause any change.

The main finding of this study is that, in the absence of circulating neutrophils, MMP-2 and MMP-9 expression and activity are still up-regulated following focal cerebral ischemia. Additionally, neutrophil depletion had no influence on indicators of ischemic brain damage including edema, hemorrhage, and infarct size. These findings indicate that, at least acutely, neutrophils are not a significant contributor of gelatinase activity associated with acute neurovascular damage after stroke.

## Linked entities

- **Proteins:** MMP2 (matrix metallopeptidase 2), MMP9 (matrix metallopeptidase 9)
- **Diseases:** stroke (MONDO:0005098)

## Full-text entities

- **Genes:** Elane (elastase, neutrophil expressed) [NCBI Gene 299606] {aka Ela2}, MMP-2 and -9 [NCBI Gene 4313;4318], Adk (adenosine kinase) [NCBI Gene 25368] {aka AK}, Vcam1 (vascular cell adhesion molecule 1) [NCBI Gene 25361] {aka VCAM1B}, Psl1 (promotion susceptibility QTL 1) [NCBI Gene 112229] {aka Tpa}, MMP-9 [NCBI Gene 101003884], Mmp8 (matrix metallopeptidase 8) [NCBI Gene 63849], Mmp2 (matrix metallopeptidase 2) [NCBI Gene 81686], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}
- **Diseases:** Brain edema (MESH:D001929), cerebral artery occlusion (MESH:D001157), Edema (MESH:D004487), ischemic hemisphere (MESH:D002544), ischemia/reperfusion injury (MESH:D015427), microvascular damage (MESH:D017566), Neutrophil depletion (MESH:C564275), inflammation (MESH:D007249), Cerebral ischemia (MESH:D002545), neurologic damage (MESH:D020196), ischemia (MESH:D007511), injury to the brain (MESH:D001930), ischemic brain damage (MESH:D001925), stroke (MESH:D020521), Infarct (MESH:D007238), neutropenic (MESH:D044504), ischemic damage (MESH:D017202), neurovascular damage (MESH:D013901), hemorrhage (MESH:D006470), MCAO (MESH:D020244), tissue injury (MESH:D017695), vascular disease (MESH:D014652),  (MESH:D009503),  (MESH:D020300)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC1190186/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC1190186/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC1190186/full.md

---
Source: https://tomesphere.com/paper/PMC1190186